XML 167 R147.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Information (Schedule of Business Segments) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Net sales $ 9,544 $ 10,268 $ 10,926
Cost of sales (7,592) (7,932) (8,343)
Gross Profit 1,952 2,336 2,583
Selling, General and Administrative Expense (899) (1,033) (1,077)
Amortization of Intangible Assets (164) (159) (164)
Research and Development Expense (125) (130) (146)
Other (charges) gains, net (1,581) (1,744) (68)
Gain (loss) on disposition of businesses and assets, net (5) (14) 505
Other segment items(2) [1] 36 24 32
Operating profit (loss) (786) (720) 1,665
Depreciation and amortization 760 801 706
Equity in net earnings (loss) of affiliates 127 196 102
Capital expenditures [2] 326 414 542
Goodwill and intangible assets, net 7,355 9,028  
Total assets 21,695 22,838  
Increase (decrease) in accrued capital expenditures (17) (21) (26)
Engineered Materials      
Segment Reporting Information [Line Items]      
Net sales 5,390 5,595 6,135
Equity in net earnings (loss) of affiliates [3] 114 182 88
Acetyl Chain      
Segment Reporting Information [Line Items]      
Net sales [4] 4,154 4,673 4,791
Other Activities      
Segment Reporting Information [Line Items]      
Equity in net earnings (loss) of affiliates 13 14 14
Operating Segments [Member] | Engineered Materials      
Segment Reporting Information [Line Items]      
Net sales 5,390 5,595 6,135
Cost of sales (4,147) (4,376) (4,828)
Gross Profit 1,243 1,219 1,307
Selling, General and Administrative Expense (401) (435) (436)
Amortization of Intangible Assets (162) (157) (162)
Research and Development Expense (85) (90) (97)
Other (charges) gains, net (1,552) (1,724) (56)
Gain (loss) on disposition of businesses and assets, net (1) (10) 509
Other segment items(2) [1] 0 0 0
Operating profit (loss) (958) (1,197) 1,065
Depreciation and amortization 447 510 462
Equity in net earnings (loss) of affiliates 105 172 83
Capital expenditures 167 211 237
Goodwill and intangible assets, net 6,917 8,617  
Total assets 13,971 15,485  
Operating Segments [Member] | Acetyl Chain      
Segment Reporting Information [Line Items]      
Net sales [5] 4,232 4,763 4,884
Cost of sales (3,525) (3,650) (3,610)
Gross Profit 707 1,113 1,274
Selling, General and Administrative Expense (111) (121) (119)
Amortization of Intangible Assets (2) (2) (2)
Research and Development Expense (40) (40) (40)
Other (charges) gains, net (11) 0 (4)
Gain (loss) on disposition of businesses and assets, net (4) (4) (4)
Other segment items(2) [1] 0 0 0
Operating profit (loss) 539 946 1,105
Depreciation and amortization 263 244 217
Equity in net earnings (loss) of affiliates 10 10 6
Capital expenditures 135 151 207
Goodwill and intangible assets, net 438 411  
Total assets 5,302 5,257  
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] | Other Activities      
Segment Reporting Information [Line Items]      
Net sales 0 0 0
Cost of sales 2 4 2
Gross Profit 2 4 2
Selling, General and Administrative Expense (387) (477) (522)
Amortization of Intangible Assets 0 0 0
Research and Development Expense 0 0 (9)
Other (charges) gains, net (18) (20) (8)
Gain (loss) on disposition of businesses and assets, net 0 0 0
Other segment items(2) [1] 36 24 32
Operating profit (loss) (367) (469) (505)
Depreciation and amortization 50 47 27
Equity in net earnings (loss) of affiliates 12 14 13
Capital expenditures 24 52 98
Goodwill and intangible assets, net 0 0  
Total assets 2,422 2,096  
Intersegment [Member]      
Segment Reporting Information [Line Items]      
Net sales (78) (90) (93)
Cost of sales 78 90 93
Gross Profit 0   0
Selling, General and Administrative Expense 0 0 0
Amortization of Intangible Assets 0 0 0
Research and Development Expense 0 0 0
Other (charges) gains, net 0 0 0
Gain (loss) on disposition of businesses and assets, net 0 0 0
Other segment items(2) [1] 0 0 0
Operating profit (loss) 0 0 0
Depreciation and amortization 0 0 0
Equity in net earnings (loss) of affiliates 0 0 0
Capital expenditures 0 0 0
Goodwill and intangible assets, net 0 0  
Total assets 0 0  
Intersegment [Member] | Acetyl Chain      
Segment Reporting Information [Line Items]      
Net sales $ 78 $ 90 $ 93
[1] Includes Foreign exchange gain (loss), net.
[2] Includes a decrease in accrued capital expenditures of $17 million, a decrease in accrued capital expenditures of $21 million and a decrease in accrued capital expenditures of $26 million for the years ended December 31, 2025, 2024 and 2023, respectively.
[3] Includes an equity method investment with losses in excess of its carrying amount due to the Company's guarantee of various debt obligations under agreements with third parties related to an equity affiliate (Note 19). This equity method investment is recorded in current Other liabilities (Note 10) in the consolidated balance sheets as of December 31, 2025 and 2024.
[4] Excludes intersegment sales of $78 million, $90 million and $93 million for the years ended December 31, 2025, 2024 and 2023, respectively.
[5] Includes intersegment sales of $78 million, $90 million and $93 million for the years ended December 31, 2025, 2024 and 2023, respectively.